APOC1 Antikörper (Biotin)
-
- Target Alle APOC1 Antikörper anzeigen
- APOC1 (Apolipoprotein C-I (APOC1))
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser APOC1 Antikörper ist konjugiert mit Biotin
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- Goat anti-Human Apo CI [B07] Antibody Biotin Conjugated
- Immunogen
- Human Apolipoprotein CI
- Klon
- B07
- Isotyp
- IgG
- Top Product
- Discover our top product APOC1 Primärantikörper
-
-
- Applikationshinweise
-
WB: 1:1,000 - 1:20,000
ELISA: 1:1,000 - 1:20,000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 1 mg/mL
- Buffer
- 75 mM Sodium Phosphate, 75 mM NaCl, 0.5 mM EDTA, 0.02 % Sodium azide, pH 7.2
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Haltbarkeit
- 12 months
-
- Target
- APOC1 (Apolipoprotein C-I (APOC1))
- Andere Bezeichnung
- ApoCI (APOC1 Produkte)
- Hintergrund
- Background: ApoCI contains 57 amino acid residues and the m.w. is 6.6 kDa (Jackson et al., 1974). ApoCI has been found to activate LCAT (Liu and Subbaiah 1993). Apo CI is an inhibitor of lipoprotein binding to the LDL receptor, LDL receptor-related protein, and VLDL receptor. Apo CI is also an inhibitor of the plasma cholesteryl ester transfer protein and of fatty acid uptake into tissues (Shachter, 2001). This inhibition role can potentially regulate several lipase enzymes. (Poensgen, 1990, Conde-Knape et al., 2002, Berbee et al., 2005)
- Gen-ID
- 341
- NCBI Accession
- NP_001636
- UniProt
- P02654
- Pathways
- Apoptose
-